A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.

NCT05029622 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ipsen